多只成分股表现强势 星石投资认为，短期看，国内暂时缺少新的驱动因素，叠加临近五一假期，海外不确定性因素仍较多， 预计市场以震荡为主。中期来看，海外扰动因素冲击最大的时刻已经过去，中国市场进一步下行风险有 所减小。全球经济秩序重构和美国政策高度不确定性的环境可能会持续，这可能导致全球资金流出美国 市场，相应非美资产有望受益。 上周市场反弹，上证指数上涨0.56%，深证成指上涨1.38%，创业板指上涨1.74%，沪深300指数上涨 0.38%，品牌工程指数上涨0.45%，报1614.56点。 上周品牌工程指数多只成分股表现强势。具体来说，科沃斯上涨12.34%，排在涨幅榜首位；信立泰上 涨9.99%，居次席；上海家化和珀莱雅涨逾9%；药明康德上涨8.53%；丸美生物、中际旭创、宁德时代 涨逾7%；华谊集团、小熊电器、石头科技涨逾5%；阳光电源、恒瑞医药、盾安环境涨逾4%；兆易创 新、恒顺醋业、新宝股份、步长制药、亿纬锂能涨逾3%。 □本报记者 王宇露 2025开年以来，上海家化上涨34.83%，排在涨幅榜首位；信立泰上涨28.19%，居次席；丸美生物和广 联达涨逾20%；安集科技上涨19.48%；韦尔股份、山西汾 ...

Core Viewpoint - Shanghai Jahwa has been undergoing significant operational adjustments since Lin Xiaohai took over in the second quarter of last year, resulting in substantial financial losses in 2024, with a focus on strategic realignment for future profitability [1][2][3]. Financial Performance - In 2024, Shanghai Jahwa reported a revenue of 5.679 billion yuan, a year-on-year decline of 13.93%, and a net loss attributable to shareholders of 833 million yuan, a decrease of 266.60% compared to the previous year [2][3]. - The previous year (2023), the company had a revenue of 6.598 billion yuan and a net profit of 500 million yuan, highlighting a stark contrast in performance [3]. - The significant losses in 2024 were primarily due to a 613 million yuan impairment charge related to goodwill from previous acquisitions in the baby care and maternal products sector [3][6]. Business Strategy and Adjustments - Since the second half of 2024, the company has adopted a strategy focused on core brands, brand building, online presence, and operational efficiency, leading to various organizational changes and business adjustments [4]. - The company’s business segments include personal care, beauty, innovation, and overseas operations, with beauty and innovation segments experiencing notable revenue declines of 29.81% and 19.38%, respectively [5]. Inventory and Pricing Strategies - Starting from the fourth quarter of 2024, Shanghai Jahwa implemented aggressive discounting strategies to clear inventory, which continued into the first quarter of 2025 [9]. - Average selling prices for personal care, beauty, and innovation products saw significant declines, with beauty products dropping by 39.16% to 7.20 yuan per unit in the fourth quarter of 2024 [11][13]. Online and Offline Channel Performance - In 2024, the company’s online revenue was 2.539 billion yuan, down 9.66%, while offline revenue was 3.136 billion yuan, down 16.97%, indicating a stronger performance in online channels despite overall declines [15][18]. - The company is committed to enhancing its online transformation and expanding into emerging offline channels, with plans to add over 100 new strategic partners in the first quarter of 2025 [17][18]. Future Outlook - Despite the challenges faced in 2024, the company aims to achieve a turnaround in profitability by the first quarter of 2025, with a reported revenue of 1.704 billion yuan, a decline of 10.59%, and a net profit of 217 million yuan, down 15.25% [19].

Investment Rating - The investment rating for the company is "Buy" with a target price of 22.8 CNY [6][17]. Core Insights - The company reported better-than-expected performance in Q1 2025, with a revenue of 17.04 billion CNY, down 10.59% year-on-year, and a net profit of 2.17 billion CNY, down 15.25% year-on-year [1]. - The company plans to implement an equity incentive plan, aiming to revitalize its operations and improve profitability over the next three years [4]. - The strategic adjustments have led to short-term pressure across various segments, but the company is expected to recover as it optimizes its business structure and channels [3]. Financial Performance Summary - For 2024, the company reported a revenue of 56.79 billion CNY, down 13.93% year-on-year, and a net profit of -8.33 billion CNY, down 266.60% year-on-year [1]. - The gross margin for 2024 was 57.60%, a decrease of 1.37 percentage points year-on-year, while the net profit margin was -14.67%, down 22.25 percentage points year-on-year [2]. - The company expects revenues of 62.3 billion CNY in 2025, 66.7 billion CNY in 2026, and 71.2 billion CNY in 2027, with corresponding net profits of 3.4 billion CNY, 4.9 billion CNY, and 5.5 billion CNY respectively [4]. Segment Performance Summary - Personal care products (including Six God and Meijiajing brands) generated 23.79 billion CNY in revenue for 2024, down 3.42% year-on-year, with a gross margin of 63.59% [3]. - The beauty segment (including Yuze, Baicaojing, Shuangmei, and Diancui brands) saw revenues of 10.50 billion CNY, down 29.81% year-on-year, with a gross margin of 69.67% [3]. - Online sales accounted for 44.74% of total revenue, generating 25.39 billion CNY, down 9.66% year-on-year, while offline sales accounted for 55.26%, generating 31.36 billion CNY, down 16.97% year-on-year [3].

Core Viewpoint - The domestic beauty market shows a stark contrast, with Proya becoming the first domestic brand to exceed 10 billion yuan in revenue, while Shanghai Jahwa faces a significant decline in net profit, marking a challenging period for the company [1][2]. Financial Performance - Shanghai Jahwa reported a revenue of 5.679 billion yuan for 2024, a year-on-year decrease of 13.93% [1]. - The company experienced a net loss of 833 million yuan, a staggering decline of 266.6% compared to the previous year, marking the largest loss since the company began publishing annual reports [1][2]. - The overseas business revenue was 1.415 billion yuan, down 11.43% year-on-year, contributing to the overall decline in profit [2][3]. Strategic Adjustments - The new CEO, Lin Xiaohai, initiated significant organizational reforms aimed at shifting the business model from "channel-driven" to "brand-driven" [1][9]. - The company undertook strategic adjustments, including reducing inventory in department stores and transitioning from an agency model to a self-operated model for online distributors, which negatively impacted current revenue [2][3]. Goodwill Impairment - The company recorded a goodwill impairment of 610 million yuan related to the acquisition of the UK infant care brand "Tommee Tippee," which was purchased for nearly 2 billion yuan in 2017 [2][3]. - The impairment was attributed to factors such as low birth rates overseas, intensified competition in the infant product category, and reduced inventory by distributors [3]. Market Position - Shanghai Jahwa's revenue has significantly lagged behind Proya, which has seen its revenue gap widen to 5 billion yuan, with Proya achieving over 10 billion yuan in annual revenue [6]. - The beauty segment of Shanghai Jahwa has been particularly underperforming, with a revenue decline of 29.81%, while the personal care segment remains the largest contributor at 2.379 billion yuan, down 3.42% [6]. Online vs. Offline Sales - The company's online revenue for 2024 was 2.539 billion yuan, a decrease of 9.66%, while offline revenue was 3.136 billion yuan, down 16.97% [6]. - The online gross margin increased by 1.8 percentage points to 63.58%, compared to 52.78% for offline channels, indicating a more favorable cost structure for online sales [6][7]. Future Outlook - Despite the poor performance in 2024, the first quarter of 2025 showed signs of recovery, with total revenue of 1.704 billion yuan, a year-on-year decline of 10.59% but a quarter-on-quarter increase of 41.73% [12]. - The company aims to enhance its online capabilities and adapt to changing consumer behaviors by focusing on interest-based e-commerce and developing content-driven online operations [10].

来源：文汇报 ■本报记者 唐闻佳 郑捷回忆，2003年，上海家化与瑞金医院皮肤科开启中国医学护肤领域最早的"医研共创"实践。这个跨 界牵手，因患者"痛点"而起。 皮肤健康不仅关乎美丽，更关乎全身健康。"研究发现，坚持皮肤屏障护理，对认知功能衰退、糖尿病 等都有一定保护作用。"近日在上海举行的全国皮肤屏障专业峰会上，瑞金医院皮肤科终身教授郑捷分 享这一前沿进展。 由瑞金医院主导的一项项研究，不仅写成论文，刷新人们对"皮肤健康"的认知，更变成了市场上的畅销 产品：被誉为"中国第一个医学护肤品"的玉泽皮肤屏障修护身体乳，多次位列平台"回购率"第一位置。 当前，我国护肤品市场正迎来前所未有的变革。《中国护肤品消费趋势报告》显示，与过去一味追求国 际大牌不同，2024年，超八成消费者表示经常购买国产护肤品。 在玉泽"叫好又叫座"的背后，"医研共创"的合作模式受到关注：瑞金医院和上海家化这两家"百年老 店"22年牵手，蹚出一条新路。 "科研基因"成国货护肤品硬核营销标签 "皮肤不仅是人体屏障，更是神经、内分泌、免疫系统'三位一体'的呈现。"郑捷介绍，近10年，三项摘 获诺贝尔奖的科研成果——Toll样受体、昼夜节律、辣椒 ...

Core Viewpoint - Shanghai Jahwa's 2024 annual report reveals a significant decline in revenue and a net loss, marking the first loss since its listing, attributed to historical issues and challenges in overseas markets [1][2] Financial Performance - The company reported a revenue of 5.679 billion yuan, a year-on-year decrease of 13.93% [1] - Net profit showed a loss of 833 million yuan, the first loss in its history [1] - The overseas business incurred a loss of approximately 100 million yuan, with goodwill impairment of about 610 million yuan [1] Strategic Adjustments - CEO Lin Xiaohai indicated that the company has been addressing long-standing issues and aims to operate with a lighter burden moving forward [1] - The company reduced 7,000 SKUs in the last quarter, optimizing inventory and product offerings [2] - Inventory turnover days in the department store channel decreased from 342 days to 89 days due to strategic adjustments [2] Future Outlook - The company is focusing on online channel development and has improved its content production capabilities for interest e-commerce [2] - Shanghai Jahwa aims to return to a growth trajectory in the new fiscal year, targeting double-digit growth and profitability recovery [2]

Core Viewpoint - Shanghai Jahwa has reported its first loss in 20 years, primarily due to the acquisition of Mayborn Group Limited, which resulted in significant goodwill impairment and operational challenges [2][5]. Financial Performance - In 2024, Shanghai Jahwa's revenue was 5.679 billion yuan, a year-on-year decline of 13.93%, with a net loss of 833 million yuan, more than doubling from the previous year [1][2]. - Mayborn's revenue and net profit for 2024 were 1.417 billion yuan and 714 million yuan, respectively, reflecting year-on-year declines of 11.49% and 880.18% [3]. Goodwill Impairment - The impairment of goodwill amounted to 613 million yuan, significantly impacting Shanghai Jahwa's financial results [2]. - As of the end of 2024, the remaining goodwill stood at 1.486 billion yuan [4]. Business Strategy and Management Changes - Following the management change, Shanghai Jahwa is re-evaluating Mayborn's business growth targets, with early signs of recovery in Q1 2025 [4][6]. - The company is undergoing a transformation that has temporarily pressured its performance [5]. Revenue Challenges - Both major product lines, personal care and beauty, experienced revenue declines in 2024, with personal care generating 2.379 billion yuan (down 3.42%) and beauty generating 1.05 billion yuan (down nearly 30%) [4]. Future Initiatives - Shanghai Jahwa's strategy for 2025 includes launching new products, focusing on online platforms while maintaining offline channels, and increasing investment in brand building [7][9]. - The company plans to collaborate with instant retail platforms like Meituan, Ele.me, and JD.com to enhance its O2O business [8]. Sales and Marketing Expenses - In 2024, sales expenses were 2.652 billion yuan, accounting for 47% of revenue, with plans to maintain the sales expense ratio while reallocating funds towards brand development [9].

上海家化董事长兼首席执行官林小海将其定义为"卸包袱"与"寻出路"的一年——砍掉历史包 袱、重塑品牌矩阵、重构渠道逻辑。这场转型背后，既有壮士断腕的决绝，也有对国货未来竞 争力的深思。 根据财报数据，2 0 2 4年，上海家化实现营业收入5 6 . 7 9亿元，同比下滑1 3 . 9 3%；归母净利润 亏 损 8 . 3 3 亿 元 ， 其 中 商 誉 减 值 6 . 1 亿 元 ， 海 外 业 务 亏 损 1 亿 元 ；2 0 2 5 年 一 季 度 ， 营 收 1 7 . 0 4 亿 元，同比下滑1 0 . 5 9%。 从表面上看，这是一份"触底"的成绩单，但，" 深蹲是为了更好地起跳。 " 林小海在媒体电话 会上表示。 4月2 4日晚，上海家化发布2 0 2 5年一季报暨2 0 2 4年报。 2 0 2 4年的中国美妆市场，K型分化加剧，国际品牌与新兴国货的夹击下，百年老牌上海家化交 出了一份"矛盾"的财报：营收利润双降，但应收账款、存货周转、现金流等指标显著优化。 2 0 2 4年，上海家化完成了深刻的业务和组织架构调整，业绩主要受到海外业务减值和国内业 务战略调整的影响。 其中，以母婴品牌汤美星为主的 ...

Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The company is undergoing a painful adjustment period in 2024, with expectations for performance recovery in 2025 [2][7] - The company has implemented strategic adjustments in its domestic business, including reducing inventory and closing underperforming stores, which has led to a temporary decline in revenue [3] - The company is focusing on online transformation and enhancing operational efficiency through organizational restructuring [3][4] - A stock incentive plan has been introduced to boost employee confidence and align interests with future performance goals [6][7] Revenue Summary - In 2024, the company achieved revenue of 5.679 billion yuan, a year-on-year decrease of 13.93% [2][9] - For Q1 2025, revenue was 1.704 billion yuan, down 10.59% year-on-year [2] - Revenue by product category in 2024: Personal Care 2.379 billion yuan (-3.42%), Beauty 1.050 billion yuan (-29.81%), Innovation 0.830 billion yuan (-19.38%), Overseas 1.415 billion yuan (-11.43%) [4] Profit Summary - The company reported a net profit of -833 million yuan in 2024, a decline of 266.60% year-on-year [2][9] - In Q1 2025, the net profit was 217 million yuan, down 15.25% year-on-year [2] - The gross margin for Q1 2025 was 63.40%, with a net margin of 12.75% [5] Future Earnings Forecast - Revenue projections for 2025-2027 are 6.199 billion yuan, 6.763 billion yuan, and 7.315 billion yuan respectively [7][9] - Expected net profits for the same period are 363 million yuan, 458 million yuan, and 533 million yuan respectively [7][9] - The earnings per share (EPS) forecast for 2025-2027 is 0.54 yuan, 0.68 yuan, and 0.79 yuan respectively [7][9]

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 27.76 [8][9]. Core Views - The company reported a revenue of RMB 5.679 billion for 2024, a year-on-year decrease of 13.93%, and a net profit attributable to shareholders of RMB -833 million, indicating a transition from profit to loss [1]. - In Q1 2025, the company achieved a revenue of RMB 1.704 billion, down 10.59% year-on-year, with a net profit of RMB 217 million, down 15.25% year-on-year. However, there are signs of improvement in actual shipments and terminal sales [1][2]. - The company has initiated an employee stock ownership plan, which is expected to enhance internal motivation and align employee interests with company performance [3]. - The company’s multi-brand online performance showed significant growth in Q1 2025, particularly on platforms like Douyin, with several brands exceeding sales targets [4]. Summary by Sections Financial Performance - The company’s revenue and profit forecasts for 2025 to 2027 are as follows: - 2025: Net profit of RMB 334 million, a year-on-year increase of 140.11% - 2026: Net profit of RMB 488 million, a year-on-year increase of 46.15% - 2027: Net profit of RMB 537 million, a year-on-year increase of 10.06% - Corresponding EPS for these years are projected at RMB 0.50, RMB 0.73, and RMB 0.80 respectively [5][7]. Segment Performance - The beauty segment experienced a revenue decline of 29.81% year-on-year in 2024, while personal care revenue decreased by 3.42% year-on-year. Online revenue for 2024 was RMB 2.539 billion, down 9.66% year-on-year, while offline revenue was RMB 3.136 billion, down 13.85% year-on-year [2]. Employee Incentives - The employee stock ownership plan involves up to 45 participants, representing 0.72% of the total share capital, with a total investment not exceeding RMB 77.51 million. The plan includes performance targets for the years 2025 to 2027 [3]. Market Position and Valuation - The company is currently valued at a price-to-sales (PS) ratio of 3 times for 2025, reflecting its ongoing transformation phase. The target price has been adjusted from RMB 24.98 to RMB 27.76 based on improved sales performance in Q1 [5][8].